Hospital
Lawrence Memorial Health Foundation INC.
Lawrence Memorial Health Foundation INC. was paid $1.74M by Medicaid between Jan 2018 and Dec 2024, across 105 billing codes. Its largest line is 97110, Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion — 10% of everything it billed.
33Billing provider infoLAWRENCE MEMORIAL HEALTH FOUNDATION INC.
WALNUT RIDGE, AR 72476
WALNUT RIDGE, AR 72476
33aNPI1194724658assigned 07/18/2005
33bProvider typeCritical Access Hospital
28Total paid$1.74M
24GClaims125,284
24DCodes billed105
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Arkansas
Rank by total paid#8 of 34
Median peer was paid$773K
This provider vs. median2.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 23,638 | $205K | |
| 2019 | 18,460 | $245K | |
| 2020 | 14,532 | $174K | |
| 2021 | 17,744 | $233K | |
| 2022 | 17,056 | $245K | |
| 2023 | 19,119 | $324K | |
| 2024incomplete | 14,735 | $317K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 10% | 4,130 | 832 | $179K |
| 70450 | Computed tomography, head or brain; without contrast material | 8.4% | 1,305 | 1,099 | $146K |
| 80053 | Comprehensive metabolic panel | 8.3% | 13,542 | 10,536 | $145K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 6.9% | 3,926 | 2,061 | $121K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.2% | 11,697 | 8,888 | $91K |
| 87428 | 5.0% | 1,432 | 1,270 | $86K | |
| 87631 | 3.5% | 541 | 498 | $62K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3.0% | 663 | 554 | $53K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.7% | 1,111 | 610 | $48K |
| 71045 | Radiologic examination, chest; single view | 2.5% | 4,325 | 3,470 | $44K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 2.4% | 3,037 | 1,442 | $41K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.3% | 1,388 | 1,138 | $41K |
93 more codes
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.3% | 2,562 | $40K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.1% | 810 | $36K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.0% | 3,445 | $35K |
| 83880 | 1.9% | 1,811 | $34K | |
| 80061 | Lipid panel | 1.7% | 2,768 | $30K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.7% | 2,775 | $30K |
| 84484 | 1.6% | 3,009 | $28K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.4% | 319 | $25K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.4% | 2,574 | $24K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.3% | 1,190 | $23K |
| 71046 | Radiologic examination, chest; 2 views | 1.3% | 1,222 | $23K |
| 81001 | 1.3% | 6,093 | $22K | |
| 83605 | 1.2% | 1,771 | $21K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.2% | 596 | $20K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.0% | 2,715 | $18K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,115 | $17K |
| 36415 | Collection of venous blood by venipuncture | <1% | 9,134 | $17K |
| 80305 | <1% | 1,218 | $17K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,120 | $16K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,349 | $16K |
| 85027 | <1% | 3,870 | $15K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 488 | $12K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 89 | $12K |
| 83690 | <1% | 1,491 | $11K | |
| 87081 | <1% | 1,173 | $10K | |
| 87040 | <1% | 1,057 | $9K | |
| 87077 | <1% | 1,800 | $9K | |
| 82607 | <1% | 673 | $8K | |
| 87186 | <1% | 1,788 | $6K | |
| 86756 | <1% | 400 | $6K | |
| 84439 | <1% | 476 | $5K | |
| 80050 | General health panel | <1% | 114 | $5K |
| 83735 | <1% | 1,142 | $5K | |
| 97161 | <1% | 57 | $5K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 17 | $5K |
| 85610 | <1% | 1,481 | $4K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 13 | $4K |
| 81025 | <1% | 493 | $4K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 65 | $4K |
| 73030 | <1% | 136 | $4K | |
| 71020 | <1% | 282 | $3K | |
| 73630 | <1% | 138 | $3K | |
| 87400 | <1% | 376 | $3K | |
| 85730 | <1% | 542 | $3K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 339 | $3K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 81 | $3K |
| 82728 | <1% | 266 | $3K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 28 | $3K |
| 82150 | <1% | 380 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 298 | $2K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 26 | $2K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 50 | $2K |
| 94760 | <1% | 483 | $2K | |
| 83540 | <1% | 330 | $2K | |
| 82962 | <1% | 366 | $1K | |
| 82805 | <1% | 74 | $1K | |
| 87070 | <1% | 170 | $1K | |
| 83550 | <1% | 187 | $1K | |
| 80320 | <1% | 74 | $1K | |
| 71010 | <1% | 207 | $1K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 18 | $999.91 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 133 | $897.50 |
| 72100 | <1% | 27 | $728.64 | |
| 73610 | <1% | 44 | $707.79 | |
| 84703 | <1% | 54 | $637.85 | |
| 97150 | Therapeutic procedure(s), group (2 or more individuals) | <1% | 89 | $551.77 |
| P9612 | Catheterization for collection of specimen, single patient, all places of service | <1% | 13 | $428.98 |
| 82550 | <1% | 52 | $410.42 | |
| A9576 | Injection, gadoteridol, (prohance multipack), per ml | <1% | 25 | $385.76 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 34 | $346.86 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 108 | $325.92 |
| 84145 | <1% | 16 | $317.02 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 2,143 | $296.55 |
| 82746 | <1% | 13 | $276.99 | |
| 74018 | <1% | 13 | $241.62 | |
| 73110 | <1% | 18 | $232.00 | |
| 80076 | <1% | 63 | $188.38 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 12 | $179.08 |
| 82947 | <1% | 87 | $160.60 | |
| 82570 | <1% | 27 | $151.95 | |
| 82043 | <1% | 14 | $97.00 | |
| 82565 | <1% | 15 | $81.93 | |
| T1502 | Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit | <1% | 564 | $62.26 |
| 99285 | Emergency room visit (most serious) | <1% | 31 | $53.55 |
| 96376 | <1% | 33 | $49.49 | |
| 81003 | <1% | 64 | $41.60 | |
| A9270 | Non-covered item or service | <1% | 262 | $21.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 162 | $12.00 |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 849 | $6.42 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 26 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 30 | $0.00 |
| 90686 | 0% | 12 | $0.00 | |
| G0378 | Hospital observation service, per hour | 0% | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWAGNER, VANESSA (CFO)
| Provider | Location | Paid |
|---|---|---|
| Lawrence Memorial Health Foundation INC. | Walnut Ridge, AR | $355K |
| Lawrence Memorial Health Foundation INC. | Walnut Ridge, AR | $328K |
| Lawrence Memorial Health Foundation INC. | Imboden, AR | $14K |
| Lawrence Memorial Hospital | Imboden, AR | $853.86 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.